(Q41371132)

30 September 2017

1 reference

title

In vivo and in vitro testing for adverse drug reactions (English)

1 reference

30 September 2017

Rieder MJ

1

1 reference

30 September 2017

publication date

1 February 1997

1 reference

Pediatric Clinics of North America

30 September 2017

published in

1 reference

30 September 2017

volume

44

1 reference

30 September 2017

issue

1

1 reference

30 September 2017

page(s)

93-111

1 reference

Desensitization to trimethoprim/sulfamethoxazole in HIV-infected patients

30 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970465-X

Allergic reactions to drugs and biologic agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970465-X

Allergic reactions to betalactams: studies in a group of patients allergic to penicillin and evaluation of cross-reactivity with cephalosporin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970465-X

Acetylation phenotype and cutaneous hypersensitivity to trimethoprim-sulphamethoxazole in HIV-infected patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970465-X

Efficacy and safety of rechallenge with low-dose trimethoprim-sulphamethoxazole in previously hypersensitive HIV-infected patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970465-X

In vitro cytotoxicity as a marker of hypersensitivity to sulphamethoxazole in patients with HIV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970465-X

Allergic reactions to drugs: current concepts and problems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970465-X

Sulfonamide hepatic injury. Review of the literature and report of a case due to sulfamethoxazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970465-X

PAF acether release on antigenic challenge. A method for the investigation of drug allergic reactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970465-X

Genetic control of isoniazid metabolism in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970465-X

Current concepts in allergy: drug reactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970465-X

Oral desensitization to trimethoprim-sulfamethoxazole in a patient with acquired immunodeficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970465-X

Lymphokine control of in vivo immunoglobulin isotype selection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970465-X

Clinical experience with penicillin skin testing in a large inner-city STD clinic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970465-X

Drug allergy: prevention, diagnosis, and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970465-X

Evaluation of penicillin hypersensitivity: value of clinical history and skin testing with penicilloyl-polylysine and penicillin G. A cooperative prospective study of the penicillin study group of the American Academy of Allergy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970465-X

Drugs as allergens: an immunoassay for detecting IgE antibodies to cephalosporins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970465-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970465-X

Adverse drug reactions: the magnitude of the problem.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970465-X

Skin testing for penicillin allergy and immediate hypersensitivity reactions to penicillin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970465-X

Altered patterns of drug metabolism in patients with acquired immunodeficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970465-X

STUDIES ON THE MECHANISMS OF HYPERSENSITIVITY PHENOMENA. IX. HISTAMINE RELEASE FROM HUMAN LEUKOCYTES BY RAGWEED POLLEN ANTIGEN.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970465-X

Evaluation of safety and tolerance in clinical trials with antimicrobial agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970465-X

Searches for ultimate chemical carcinogens and their reactions with cellular macromolecules.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970465-X

The appropriate use of skin testing and allergen immunotherapy in young children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970465-X

Immunologic cross-reactivity between penicillins and cephalosporins: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970465-X

Cytokines and endothelial cell biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970465-X

The role of skin testing for penicillin allergy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970465-X

Immunopharmacology and adverse drug reactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970465-X

Mechanisms of unpredictable adverse drug reactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970465-X

Prominence of slow acetylator phenotype among patients with sulfonamide hypersensitivity reactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970465-X

Diagnosis of sulfonamide hypersensitivity reactions by in-vitro "rechallenge" with hydroxylamine metabolites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970465-X

Immediate hypersensitivity reactions to beta-lactam antibiotics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970465-X

Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970465-X

In vitro evaluation of a toxic metabolite of sulfadiazine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970465-X

Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970465-X

Penicillin Hypersensitivity—A Review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970465-X

The frequency of skin test reactions to side-chain penicillin determinants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970465-X

Trimethoprim-sulfamethoxazole desensitization in the acquired immunodeficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970465-X

Results of the National Institute of Allergy and Infectious Diseases Collaborative Clinical Trial to test the predictive value of skin testing with major and minor penicillin derivatives in hospitalized adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970465-X

Penicillin allergy: clinical experience with a battery of skin-test reagents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970465-X

Non-fatal anaphylaxis caused by ampicillin scratch-test. Report of case

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970465-X

Application of leucocyte migration tests to detection of allergenic drugs in patients with hypersensitivity to beta-lactam antibiotics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970465-X

Diagnostic tests for patients with suspected allergic disease. Utility and limitations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970465-X

Skin testing for penicillin allergy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970465-X

Interleukins and tumor necrosis factor in inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970465-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970465-X

Allergy to beta-lactams: a survey of current practices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970465-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970465-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970465-X

1 reference

7 January 2021

Diagnosis of penicillin allergy by means of Phadebas RAST penicilloyl G and V and skin tests

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970465-X

7 January 2021

Drug allergy and protocols for management of drug allergies

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970465-X

7 January 2021

10.1016/S0031-3955(05)70465-X

Identifiers

DOI

1 reference

30 September 2017

1 reference